Uncategorized

Michael Hoehn II named inaugural NextGen MURR program director

June 4, 2024 — The University of Missouri has selected Michael Hoehn II as the inaugural program director for NextGen MURR.

Innovative yttrium-90 transforms liver cancer treatment

March 28, 2024 — Liver cancer is one of the deadliest forms of the disease, with an estimated 71 percent mortality rate for patients in the U.S. diagnosed with primary liver and intrahepatic bile duct cancer.

Adding a radioisotope to the toolkit for saving lives

Feb. 27, 2024 — Ground-breaking innovation provides patients around the world with access to a lifesaving toolbox of vital pharmaceutical ingredients called radioisotopes produced at MURR.

MU Health Care pilots treatment for prostate cancer

Dec. 13, 2023 — University of Missouri Health Care has initiated its first treatment using an FDA-approved targeted radioactive medicine for advanced metastatic prostate cancer.

MURR ships radioisotope for cancer treatment

Dec. 6, 2023 — The University of Missouri Research Reactor (MURR) recently completed its first commercial shipment of no-carrier-added lutetium-177 for human use and is providing weekly deliveries to Novartis for use in cancer treatments.

MU breaks ground on MURR addition

Oct. 2, 2023 — The University of Missouri hosted a groundbreaking ceremony today for a 47,000-square-foot addition to the MU Research Reactor (MURR) facility.

Matt Sanford named executive director for MURR 

July 13, 2023 — University of Missouri President Mun Choi has announced Matt Sanford as executive director for the University of Missouri’s Research Reactor (MURR).

MURR continues to bolster domestic supply chain of radioisotopes

July 13, 2023 — Continuing as an essential leader in domestic isotope production, MURR began production of iron-59 (Fe-59) and manganese-54 (Mn-54) radioisotopes.

MURR announces FDA submission for new radioisotope process

June 23, 2023 — MURR has reached a significant milestone on its path to production of no-carrier-added lutetium-177 (NCA Lu-177), a highly pure radionuclide.

A chance at ‘upcycling’ life

Oct. 12, 2022 — Diana Pummill has always struggled with “just sitting around.” So, when she’s not spending time with her husband, Gerry, her children or her grandchildren, she can often be found upcycling — a crafting hobby she developed from a lifelong passion of letting her creativity run wild.